Cost-effectiveness of ranibizumab for the treatment of...

Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system

Aljoscha S. Neubauer, Frank G. Holz, Stefan Sauer, Timo Wasmuth, Christoph Hirneiss, Anselm Kampik, Wolfgang Schrader
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Year:
2010
Language:
english
Pages:
14
DOI:
10.1016/j.clinthera.2010.07.010
File:
PDF, 145 KB
english, 2010
Conversion to is in progress
Conversion to is failed